🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT07155993
Enrolling by invitation Observational

FastForward: A Prospective Analysis of Long-term Fasting and Subsequent Food Reintroduction in Humans

NCT07155993 · tracked via the Priya Life Science Germany tracker
Sponsor
Buchinger Wilhelmi Development & Holding GmbH
Phase
Observational
Started
2024-08-01
Last updated
2025-09-10

Condition(s) studied

Diabetes (DM)Pre DiabetesOverweight (BMI > 25)

Study summary

This study explores what happens in the body and wellbeing during and after a period of long-term fasting. At the Buchinger Wilhelmi Clinic, participants follow a medically supervised fasting program lasting five or more days, followed by a structured food reintroduction phase. The study observes participants over time to better understand how fasting and the return to eating affect weight, metabolism, nutrition habits, and overall well-being.

All participants will complete online questionnaires during the fasting phase and for up to three months afterward. These surveys help track changes in lifestyle, mood, and health. In addition during the first two weeks after fasting ends participants wear a continuous glucose monitor (CGM) to track blood sugar levels in real time, use a mobile app to document meals with photos, and perform simple at-home blood tests using dried blood spot (DBS) kits.

By combining digital tools with personal reports and at home tests, the study aims to gain a clearer picture of how the body adapts after a prolonged fast. The goal is to better understand the short- and medium-term effects of extended fasting on metabolism, diet, and well-being-and to provide practical guidance for those interested in fasting as a health practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Men and women * Fasting for 5+ days at the Buchinger Wilhelmi clinic in Überlingen or Marbella * Age: 18-90 years old * Signed informed consent Exclusion Criteria: * Not able to sign the informed consent * Diagnosed with cachexia, anorexia nervosa, advanced kidney, liver or cerebrovascular insufficiency. * Chronic manifest psychical and psychiatric diseases * Participation in another study * Pregnancy or breastfeeding

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Buchinger Wilhelmi Klinik Überlingen Baden-Wurttemberg

More Buchinger Wilhelmi Development & Holding GmbH trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07155993 on ClinicalTrials.gov ↗ ← All trials in Germany